Microtubule Affinity-regulating Kinase 2 (MARK2) turns on phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) at Thr-313, a mutation site in Parkinson disease: Effects on mitochondrial transport

Journal of Biological Chemistry

Volumn 287, Issue 11, 2012, Pages 8174-8186

  Matenia, Dorthe ^a   Hempp, Cindy ^a   Timm, Thomas ^a   Eikhof, Annika ^a   Mandelkow, Eva Maria ^a,b  

^a DESY   (Germany)

^b CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANTEROGRADE TRANSPORTS; CELL PROCESS; COLOCALIZE; MICROTUBULES; MUTATION SITES; NEURODEGENERATION; PARKINSON DISEASE; PHOSPHORYLATION SITES; TOXIC EFFECT;

AMINO ACIDS; DISEASES; PHOSPHATASES; PHOSPHORYLATION;

MITOCHONDRIA;

GLUTAMIC ACID; METHIONINE; MICROTUBULE AFFINITY REGULATING KINASE 2; PHOSPHATASE; PHOSPHOTRANSFERASE; PINK1 PROTEIN; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; BRAIN NERVE CELL; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; MITOCHONDRION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

AMINO ACID SUBSTITUTION; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; HEK293 CELLS; HUMANS; MITOCHONDRIA; MUTATION, MISSENSE; NEURONS; PARKINSON DISEASE; PC12 CELLS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RATS; SPODOPTERA; THREONINE;

EID: 84858022944     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.262287     Document Type: Article

References (55)

1. Thies, E., and Mandelkow, E. M. (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J. Neurosci. 27, 2896-2907 (Pubitemid 46438993)
2. Matenia, D., and Mandelkow, E. M. (2009) The tau of MARK: a polarized view of the cytoskeleton. Trends Biochem. Sci. 34, 332-342
3. Timm, T., Li, X. Y., Biernat, J., Jiao, J., Mandelkow, E., Vandekerckhove, J., and Mandelkow, E. M. (2003) MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J. 22, 5090-5101 (Pubitemid 37222029)
4. Timm, T., Balusamy, K., Li, X., Biernat, J., Mandelkow, E., and Mandelkow, E. M. (2008) Glycogen synthase kinase (GSK) 3β directly phosphorylates Serine 212 in the regulatory loop and inhibits microtubule affinity-regulating kinase (MARK) 2. J. Biol. Chem. 283, 18873-18882
5. Lizcano, J. M., Göransson, O., Toth, R., Deak, M., Morrice, N. A., Boudeau, J., Hawley, S. A., Udd, L., Mäkelä, T. P., Hardie, D. G., and Alessi, D. R. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 23, 833-843 (Pubitemid 38418750)
6. Matenia, D., Griesshaber, B., Li, X. Y., Thiessen, A., Johne, C., Jiao, J., Mandelkow, E., and Mandelkow, E. M. (2005) PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin. Mol. Biol. Cell 16, 4410-4422 (Pubitemid 41262907)
7. Elbert, M., Rossi, G., and Brennwald, P. (2005) The yeast par-1 homologs kin1 and kin2 show genetic and physical interactions with components of the exocytic machinery. Mol. Biol. Cell 16, 532-549 (Pubitemid 40165553)
8. Panneerselvam, S., Marx, A., Mandelkow, E. M., and Mandelkow, E. (2006) Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/Par-1. Structure 14, 173-183 (Pubitemid 43202007)
9. Deng, H., Jankovic, J., Guo, Y., Xie, W., and Le, W. (2005) Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SHSY5Y. Biochem. Biophys. Res. Commun. 337, 1133-1138 (Pubitemid 41505244)
10. Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W. P., Latchman, D. S., Harvey, R. J., Dallapiccola, B., Auburger, G., and Wood, N. W. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160 (Pubitemid 38661852)
11. Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. Y., Abramov, A. S., Miljan, E. A., Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., Deas, E., Downward, J., Mansfield, L., Jat, P., Taylor, J., Heales, S., Duchen, M. R., Latchman, D., Tabrizi, S. J., and Wood, N. W. (2008) PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One 3, e2455
12. Deas, E., Plun-Favreau, H., and Wood, N. W. (2009) PINK1 function in health and disease. EMBO Mol. Med. 1, 152-165
13. Pogson, J. H., Ivatt, R. M., and Whitworth, A. J. (2011) Molecular mechanisms of PINK1-related neurodegeneration. Curr. Neurol. Neurosci. Rep. 11, 283-290
14. Beilina, A., Van Der Brug, M., Ahmad, R., Kesavapany, S., Miller, D. W., Petsko, G. A., and Cookson, M. R. (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl. Acad. Sci. U.S.A. 102, 5703-5708 (Pubitemid 40559623)
15. Weihofen, A., Ostaszewski, B., Minami, Y., and Selkoe, D. J. (2008) Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. Hum. Mol. Genet. 17, 602-616 (Pubitemid 351201772)
16. Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., and Guo, M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162-1166 (Pubitemid 43990738)
17. Exner, N., Treske, B., Paquet, D., Holmström, K., Schiesling, C., Gispert, S., Carballo-Carbajal, I., Berg, D., Hoepken, H. H., Gasser, T., Krüger, R., Winklhofer, K. F., Vogel, F., Reichert, A. S., Auburger, G., Kahle, P. J., Schmid, B., and Haass, C. (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J. Neurosci. 27, 12413-12418 (Pubitemid 350085485)
18. Gautier, C. A., Kitada, T., and Shen, J. (2008) Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 105, 11364-11369
19. Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J. M., and Chung, J. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157-1161 (Pubitemid 43990737)
20. Poole, A. C., Thomas, R. E., Andrews, L. A., McBride, H. M., Whitworth, A. J., and Pallanck, L. J. (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc. Natl. Acad. Sci. U.S.A. 105, 1638-1643 (Pubitemid 351346567)
21. Gandhi, S., Muqit, M. M., Stanyer, L., Healy, D. G., Abou-Sleiman, P. M., Hargreaves, I., Heales, S., Ganguly, M., Parsons, L., Lees, A. J., Latchman, D. S., Holton, J. L., Wood, N. W., and Revesz, T. (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain 129, 1720-1731 (Pubitemid 43999406)
22. Pridgeon, J. W., Olzmann, J. A., Chin, L. S., and Li, L. (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 5, e172
23. Haque, M. E., Thomas, K. J., D'Souza, C., Callaghan, S., Kitada, T., Slack, R. S., Fraser, P., Cookson, M. R., Tandon, A., and Park, D. S. (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc. Natl. Acad. Sci. U.S.A. 105, 1716-1721 (Pubitemid 351346580)
24. Zhou, C., Huang, Y., Shao, Y., May, J., Prou, D., Perier, C., Dauer, W., Schon, E. A., and Przedborski, S. (2008) The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc. Natl. Acad. Sci. U.S.A. 105, 12022-12027
25. Lin, W., and Kang, U. J. (2008) Characterization of PINK1 processing, stability, and subcellular localization. J. Neurochem. 106, 464-474 (Pubitemid 351840220)
26. Mills, R. D., Sim, C. H., Mok, S. S., Mulhern, T. D., Culvenor, J. G., and Cheng, H. C. (2008) Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J. Neurochem. 105, 18-33 (Pubitemid 351441646)
27. Silvestri, L., Caputo, V., Bellacchio, E., Atorino, L., Dallapiccola, B., Valente, E. M., and Casari, G. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 14, 3477-3492 (Pubitemid 41672130)
28. Stamer, K., Vogel, R., Thies, E., Mandelkow, E., and Mandelkow, E. M. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156, 1051-1063 (Pubitemid 34839854)
29. Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J. H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., Jiang, Y., Duff, K., Uchiyama, Y., Näslund, J., Mathews, P. M., Cataldo, A. M., and Nixon, R. A. (2005) Macroautophagy-a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 171, 87-98 (Pubitemid 41434604)
30. Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E. M., and Mandelkow, E. (1997) MARK, a novel family of protein kinases that phosphorylate microtubule- associated proteins and trigger microtubule disruption. Cell 89, 297-308 (Pubitemid 27199901)
31. Boyle, W. J., van der Geer, P., and Hunter, T. (1991) Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201, 110-149
32. Trinczek, B., Ebneth, A., Mandelkow, E. M., and Mandelkow, E. (1999) Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J. Cell Sci. 112, 2355-2367 (Pubitemid 29381026)
33. Klein, C., and Schlossmacher, M. G. (2007) Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Neurology 69, 2093-2104 (Pubitemid 350175712)
34. Sim, C. H., Lio, D. S., Mok, S. S., Masters, C. L., Hill, A. F., Culvenor, J. G., and Cheng, H. C. (2006) C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum. Mol. Genet. 15, 3251-3262 (Pubitemid 44605504)
35. Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R. J., McDonald, N., Wood, N. W., Martins, L. M., and Downward, J. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat. Cell Biol. 9, 1243-1252 (Pubitemid 350042356)
36. Weihofen, A., Thomas, K. J., Ostaszewski, B. L., Cookson, M. R., and Selkoe, D. J. (2009) Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 48, 2045-2052
37. Schmitt-Ulms, G., Matenia, D., Drewes, G., and Mandelkow, E. M. (2009) Interactions of MAP/microtubule affinity regulating kinases with the adaptor complex AP-2 of clathrin-coated vesicles. Cell. Motil. Cytoskeleton 66, 661-672
38. Detmer, S. A., and Chan, D. C. (2007) Functions and dysfunctions of mitochondrial dynamics. Nat. Rev. Mol. Cell Biol. 8, 870-879 (Pubitemid 47622562)
39. Augustinack, J. C., Schneider, A., Mandelkow, E. M., and Hyman, B. T. (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103, 26-35 (Pubitemid 36075309)
40. Cookson, M. R., and Bandmann, O. (2010) Parkinson's disease: insights from pathways. Hum. Mol. Genet. 19, R21-R27
41. Winklhofer, K. F., and Haass, C. (2010) Mitochondrial dysfunction in Parkinson's disease. Biochim. Biophys. Acta 1802, 29-44
42. Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D. F., Gautier, C. A., Shen, J., Cookson, M. R., and Youle, R. J. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 8, e1000298
43. Lin, W., and Kang, U. J. (2010) Structural determinants of PINK1 topology and dual subcellular distribution. BMC Cell Biol. 11, 90-102
44. Kim, Y., Park, J., Kim, S., Song, S., Kwon, S. K., Lee, S. H., Kitada, T., Kim, J. M., and Chung, J. (2008) PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem. Biophys. Res. Commun. 377, 975-980
45. Narendra, D. P., and Youle, R. J. (2011) Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. Antioxid. Redox Signal. 14, 1929-1938
46. Deas, E., Wood, N. W., and Plun-Favreau, H. (2011) Mitophagy and Parkinson's disease: the PINK1-parkin link. Biochim. Biophys. Acta 1813, 623-633
47. Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y. L., Selkoe, D., Rice, S., Steen, J., LaVoie, M. J., and Schwarz, T. L. (2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147, 893-906
48. Miller, K. E., and Sheetz, M. P. (2004) Axonal mitochondrial transport and potential are correlated. J. Cell Sci. 117, 2791-2804 (Pubitemid 38997261)
49. Jin, S. M., Lazarou, M., Wang, C., Kane, L. A., Narendra, D. P., and Youle, R. J. (2010) Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 191, 933-942
50. Vives-Bauza, C., and Przedborski, S. (2011) Mitophagy: the latest problem for Parkinson's disease. Trends Mol. Med. 17, 158-165
51. Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., and Springer, W. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12, 119-131
52. Goldstein, A. Y., Wang, X., and Schwarz, T. L. (2008) Axonal transport and the delivery of pre-synaptic components. Curr. Opin. Neurobiol. 18, 495-503
53. Colin, E., Zala, D., Liot, G., Rangone, H., Borrell-Pagès, M., Li, X. J., Saudou, F., and Humbert, S. (2008) Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons.EMBO J. 27, 2124-2134
54. Sen, S., Webber, P. J., and West, A. B. (2009) Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. J. Biol. Chem. 284, 36346-36356
55. Russo, G. J., Louie, K., Wellington, A., Macleod, G. T., Hu, F., Panchumarthi, S., and Zinsmaier, K. E. (2009) Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport. J. Neurosci. 29, 5443-5455